Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 5 | 2014 | 570 | 1.290 |
Why?
|
| Adenoviridae | 3 | 2012 | 340 | 0.820 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 2 | 2 | 2014 | 3 | 0.810 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2014 | 30 | 0.800 |
Why?
|
| Capillary Permeability | 4 | 2016 | 131 | 0.640 |
Why?
|
| Endothelial Cells | 9 | 2016 | 477 | 0.640 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2009 | 29 | 0.590 |
Why?
|
| Genetic Vectors | 4 | 2013 | 422 | 0.570 |
Why?
|
| Gene Knockdown Techniques | 6 | 2016 | 254 | 0.550 |
Why?
|
| Triazines | 2 | 2014 | 54 | 0.500 |
Why?
|
| Imidazoles | 2 | 2014 | 138 | 0.500 |
Why?
|
| Chylomicrons | 1 | 2016 | 12 | 0.490 |
Why?
|
| Lysophosphatidylcholines | 1 | 2016 | 17 | 0.490 |
Why?
|
| Lymph | 1 | 2016 | 14 | 0.480 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2016 | 1245 | 0.470 |
Why?
|
| Docosahexaenoic Acids | 1 | 2016 | 35 | 0.470 |
Why?
|
| Dietary Fats | 1 | 2016 | 135 | 0.460 |
Why?
|
| Cyclic GMP | 3 | 2014 | 62 | 0.450 |
Why?
|
| Rats | 8 | 2016 | 4072 | 0.440 |
Why?
|
| Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2014 | 1 | 0.440 |
Why?
|
| Genetic Therapy | 2 | 2008 | 366 | 0.430 |
Why?
|
| Nerve Regeneration | 1 | 2014 | 34 | 0.430 |
Why?
|
| Catenins | 2 | 2011 | 11 | 0.420 |
Why?
|
| Stress, Psychological | 2 | 2014 | 342 | 0.420 |
Why?
|
| Glutamic Acid | 1 | 2014 | 147 | 0.410 |
Why?
|
| Connexin 43 | 1 | 2014 | 94 | 0.410 |
Why?
|
| Hippocampus | 2 | 2014 | 452 | 0.410 |
Why?
|
| Fatty Acids | 1 | 2014 | 145 | 0.400 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2014 | 66 | 0.400 |
Why?
|
| Cardiomegaly | 2 | 2017 | 111 | 0.390 |
Why?
|
| Malate Dehydrogenase | 1 | 2012 | 9 | 0.380 |
Why?
|
| Artifacts | 1 | 2014 | 243 | 0.380 |
Why?
|
| Pharmacological Phenomena | 1 | 2012 | 1 | 0.380 |
Why?
|
| Neurons | 2 | 2014 | 1582 | 0.380 |
Why?
|
| Cognition Disorders | 1 | 2014 | 236 | 0.380 |
Why?
|
| Pharmacology, Clinical | 1 | 2012 | 9 | 0.380 |
Why?
|
| Pharmaceutical Preparations | 1 | 2014 | 97 | 0.370 |
Why?
|
| Cognition | 2 | 2014 | 627 | 0.370 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2012 | 17 | 0.370 |
Why?
|
| Corticosterone | 1 | 2012 | 35 | 0.370 |
Why?
|
| Lipopolysaccharides | 3 | 2016 | 301 | 0.370 |
Why?
|
| Drug Therapy | 1 | 2012 | 68 | 0.370 |
Why?
|
| Neuronal Plasticity | 1 | 2014 | 194 | 0.360 |
Why?
|
| Cyclic AMP | 3 | 2014 | 276 | 0.360 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2014 | 202 | 0.350 |
Why?
|
| MicroRNAs | 2 | 2014 | 580 | 0.340 |
Why?
|
| Signal Transduction | 9 | 2017 | 3502 | 0.340 |
Why?
|
| Energy Metabolism | 3 | 2017 | 299 | 0.340 |
Why?
|
| Lung | 3 | 2014 | 1366 | 0.310 |
Why?
|
| Inflammation | 3 | 2016 | 1050 | 0.310 |
Why?
|
| Up-Regulation | 1 | 2011 | 730 | 0.280 |
Why?
|
| Pulmonary Artery | 3 | 2016 | 333 | 0.280 |
Why?
|
| Carrier Proteins | 2 | 2008 | 663 | 0.270 |
Why?
|
| Acute-Phase Proteins | 1 | 2008 | 36 | 0.270 |
Why?
|
| Myocardial Contraction | 1 | 2008 | 188 | 0.270 |
Why?
|
| Oxidation-Reduction | 4 | 2017 | 410 | 0.260 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2007 | 9 | 0.260 |
Why?
|
| Heparin | 1 | 2008 | 181 | 0.260 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 208 | 0.250 |
Why?
|
| Cells, Cultured | 8 | 2016 | 2850 | 0.250 |
Why?
|
| Heart | 1 | 2009 | 522 | 0.250 |
Why?
|
| Immunologic Factors | 1 | 2008 | 176 | 0.250 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 87 | 0.240 |
Why?
|
| Algorithms | 1 | 2014 | 1953 | 0.240 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2016 | 78 | 0.230 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 444 | 0.230 |
Why?
|
| Animals | 12 | 2017 | 28155 | 0.220 |
Why?
|
| RNA, Small Interfering | 4 | 2014 | 555 | 0.210 |
Why?
|
| Thrombin | 2 | 2014 | 60 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 1914 | 0.190 |
Why?
|
| Inflammation Mediators | 3 | 2016 | 159 | 0.190 |
Why?
|
| Cell Line | 3 | 2014 | 2464 | 0.190 |
Why?
|
| Endothelium, Vascular | 3 | 2016 | 436 | 0.180 |
Why?
|
| Calsequestrin | 2 | 2012 | 2 | 0.170 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2013 | 10 | 0.160 |
Why?
|
| Gene Transfer Techniques | 2 | 2012 | 154 | 0.160 |
Why?
|
| Primary Health Care | 2 | 2014 | 378 | 0.150 |
Why?
|
| Phosphocreatine | 2 | 2009 | 14 | 0.150 |
Why?
|
| Mitochondria, Heart | 2 | 2009 | 48 | 0.150 |
Why?
|
| Animals, Newborn | 2 | 2012 | 522 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2009 | 295 | 0.140 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 2 | 2016 | 17 | 0.140 |
Why?
|
| Adenosine Triphosphate | 2 | 2009 | 319 | 0.140 |
Why?
|
| Phosphorylation | 3 | 2016 | 1133 | 0.130 |
Why?
|
| Cardiac Catheterization | 2 | 2012 | 295 | 0.130 |
Why?
|
| Liver | 2 | 2016 | 1210 | 0.130 |
Why?
|
| Male | 8 | 2017 | 44557 | 0.130 |
Why?
|
| Phospholipases A2 | 1 | 2016 | 44 | 0.120 |
Why?
|
| Gene Expression | 2 | 2014 | 1301 | 0.120 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2016 | 33 | 0.120 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 214 | 0.120 |
Why?
|
| Duodenum | 1 | 2016 | 110 | 0.120 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2016 | 76 | 0.110 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2016 | 84 | 0.110 |
Why?
|
| Isolated Heart Preparation | 1 | 2014 | 1 | 0.110 |
Why?
|
| Time Factors | 3 | 2008 | 5410 | 0.110 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2014 | 9 | 0.110 |
Why?
|
| Carbenoxolone | 1 | 2014 | 5 | 0.110 |
Why?
|
| Metabolic Clearance Rate | 1 | 2014 | 117 | 0.110 |
Why?
|
| Mice, Inbred ICR | 1 | 2014 | 75 | 0.110 |
Why?
|
| Myosin Light Chains | 1 | 2014 | 25 | 0.110 |
Why?
|
| Cortactin | 1 | 2014 | 11 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2017 | 379 | 0.110 |
Why?
|
| Intracellular Space | 1 | 2014 | 38 | 0.110 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2014 | 18 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 66 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 75 | 0.100 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2014 | 86 | 0.100 |
Why?
|
| Humans | 15 | 2016 | 93515 | 0.100 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 57 | 0.100 |
Why?
|
| Paxillin | 1 | 2014 | 59 | 0.100 |
Why?
|
| Microtubules | 1 | 2014 | 134 | 0.100 |
Why?
|
| Muscle, Skeletal | 2 | 2008 | 474 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2013 | 696 | 0.100 |
Why?
|
| Diabetic Retinopathy | 1 | 2014 | 82 | 0.100 |
Why?
|
| Gap Junctions | 1 | 2014 | 146 | 0.100 |
Why?
|
| Models, Biological | 2 | 2011 | 1768 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 185 | 0.100 |
Why?
|
| Interleukin-8 | 2 | 2016 | 88 | 0.100 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2012 | 6 | 0.100 |
Why?
|
| Myocardial Reperfusion | 1 | 2012 | 24 | 0.100 |
Why?
|
| Drug Administration Routes | 1 | 2012 | 20 | 0.100 |
Why?
|
| Biotransformation | 1 | 2012 | 46 | 0.090 |
Why?
|
| Drug Dosage Calculations | 1 | 2012 | 15 | 0.090 |
Why?
|
| Pharmacokinetics | 1 | 2012 | 10 | 0.090 |
Why?
|
| Actin Cytoskeleton | 1 | 2014 | 196 | 0.090 |
Why?
|
| Carbazoles | 1 | 2012 | 31 | 0.090 |
Why?
|
| Retina | 1 | 2014 | 215 | 0.090 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 136 | 0.090 |
Why?
|
| Physicians, Primary Care | 1 | 2014 | 109 | 0.090 |
Why?
|
| DNA, Complementary | 1 | 2012 | 384 | 0.090 |
Why?
|
| Drug Monitoring | 1 | 2012 | 119 | 0.090 |
Why?
|
| RNA Interference | 1 | 2013 | 379 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2014 | 408 | 0.090 |
Why?
|
| Prefrontal Cortex | 1 | 2013 | 149 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2014 | 960 | 0.080 |
Why?
|
| Transfection | 1 | 2012 | 880 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2011 | 177 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 376 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1922 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 313 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 688 | 0.080 |
Why?
|
| Palmitates | 1 | 2009 | 17 | 0.080 |
Why?
|
| Myocardial Stunning | 1 | 2009 | 10 | 0.080 |
Why?
|
| Neutrophils | 1 | 2011 | 324 | 0.080 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 1117 | 0.080 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2009 | 56 | 0.070 |
Why?
|
| Isoproterenol | 1 | 2008 | 57 | 0.070 |
Why?
|
| Citric Acid Cycle | 1 | 2008 | 28 | 0.070 |
Why?
|
| Mitochondria | 1 | 2012 | 612 | 0.070 |
Why?
|
| Depression | 1 | 2013 | 544 | 0.070 |
Why?
|
| Palmitic Acid | 1 | 2008 | 29 | 0.070 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2008 | 69 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2715 | 0.070 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 19 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 603 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 119 | 0.070 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2008 | 32 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 641 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 948 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 962 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 88 | 0.070 |
Why?
|
| Radioimmunoassay | 1 | 2007 | 144 | 0.060 |
Why?
|
| Kinetics | 1 | 2009 | 1492 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 251 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2007 | 79 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2012 | 2026 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2008 | 276 | 0.060 |
Why?
|
| Malaria, Falciparum | 1 | 2006 | 15 | 0.060 |
Why?
|
| von Willebrand Factor | 1 | 2006 | 40 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2008 | 702 | 0.060 |
Why?
|
| Lac Operon | 1 | 2005 | 43 | 0.060 |
Why?
|
| Hemodynamics | 1 | 2008 | 713 | 0.060 |
Why?
|
| Pregnancy | 1 | 2012 | 3147 | 0.060 |
Why?
|
| Transgenes | 1 | 2005 | 171 | 0.050 |
Why?
|
| Perfusion | 1 | 2005 | 260 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 578 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2016 | 784 | 0.050 |
Why?
|
| Heart Diseases | 1 | 2005 | 257 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2010 | 1691 | 0.040 |
Why?
|
| Mice | 2 | 2013 | 12269 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 2495 | 0.040 |
Why?
|
| Brain | 1 | 2011 | 2391 | 0.040 |
Why?
|
| Cell Adhesion | 2 | 2016 | 416 | 0.040 |
Why?
|
| Adipose Tissue, White | 1 | 2017 | 28 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 1 | 2017 | 96 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 58 | 0.030 |
Why?
|
| Adherens Junctions | 1 | 2016 | 34 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 248 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 398 | 0.030 |
Why?
|
| Hemostatics | 1 | 2014 | 60 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 290 | 0.020 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2013 | 4 | 0.020 |
Why?
|
| Maze Learning | 1 | 2013 | 32 | 0.020 |
Why?
|
| Lentivirus | 1 | 2013 | 44 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2016 | 423 | 0.020 |
Why?
|
| Vomiting | 1 | 2013 | 108 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2013 | 109 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 296 | 0.020 |
Why?
|
| Obesity | 1 | 2017 | 1018 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 3435 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 390 | 0.020 |
Why?
|
| Cattle | 1 | 2010 | 397 | 0.020 |
Why?
|
| Female | 1 | 2012 | 48702 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2010 | 439 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2010 | 443 | 0.020 |
Why?
|
| Malaria, Cerebral | 1 | 2006 | 4 | 0.020 |
Why?
|
| ABO Blood-Group System | 1 | 2006 | 59 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2006 | 135 | 0.010 |
Why?
|
| Blood Platelets | 1 | 2006 | 150 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2006 | 239 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2006 | 204 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1985 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 3220 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2006 | 3829 | 0.010 |
Why?
|
| Child | 1 | 2006 | 7355 | 0.010 |
Why?
|